focus -WSS

focus

author：leisure time 2025-09-28 11:02:49 - browse：58426

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： European regulators recommend Amylyx's ALS drug be rejected

Wikipedia

WSS

Profiling embryos to choose those with higher IQs is almost a reality

At JPM 2024, hospital systems pitch financial strength to investors

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

What the Wegovy shortage looks like for doctors — and for patients

Better Therapeutics data on benefit with GLP

Eight reasons why you should get an updated Covid vaccine

explore

focus

leisure time

Hollywood unions extend contract negotiations for actors

Eight reasons why you should get an updated Covid vaccine

United colonoscopy coverage change 'may cost lives,' doctors say

Researchers CRISPR chickens in bid to protect them from bird flu

Moonlake's readout produced a cash windfall. Risks remain

Researchers CRISPR chickens in bid to protect them from bird flu

Virginia high school admissions case could be legal follow

Female surgeons have lower rates of long

ChatGPT in medicine: STAT answers readers' burning questions

Better Therapeutics data on benefit with GLP

knowledge

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Better Therapeutics data on benefit with GLP

How clinical AI models' predictive power can degrade over time

Cancer cells are shown to suck energy source from immune cells

Does Paxlovid work in people vaccinated against Covid

How should state employee insurance handle Wegovy?

explore

Wikipedia

focus

knowledge